Minocycline Has No Clear Role in the Treatment of Mycobacterium abscessus Disease

about

Minocycline Has No Clear Role in the Treatment of Mycobacterium abscessus Disease

Item

http://www.wikidata.org/entity/Q57842112

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 24 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Minocycline Has No Clear Role in the Treatment of Mycobacterium abscessus Disease

@en

Minocycline Has No Clear Role in the Treatment of Mycobacterium abscessus Disease

@nl

type

Item

label

Minocycline Has No Clear Role in the Treatment of Mycobacterium abscessus Disease

@en

Minocycline Has No Clear Role in the Treatment of Mycobacterium abscessus Disease

@nl

prefLabel

Minocycline Has No Clear Role in the Treatment of Mycobacterium abscessus Disease

@en

Minocycline Has No Clear Role in the Treatment of Mycobacterium abscessus Disease

@nl

P1476

Minocycline Has No Clear Role in the Treatment of Mycobacterium abscessus Disease

@en

P2093

Cecile Magis-Escurra

http://www.w3.org/2001/XMLSchema#string

Heiman F L Wertheim

http://www.w3.org/2001/XMLSchema#string

Jodie A Schildkraut

http://www.w3.org/2001/XMLSchema#string

Wouter Hoefsloot

http://www.w3.org/2001/XMLSchema#string

P2860

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary

Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin

Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium.

Mycobacterium abscessus: a new antibiotic nightmare.

Time-kill kinetics of antibiotics active against rapidly growing mycobacteria.

Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria.

Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects.

Inhibition of the β-Lactamase BlaMab by Avibactam Improves the In Vitro and In Vivo Efficacy of Imipenem against Mycobacterium abscessus.

British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).

Uptake of antibiotics by human alveolar macrophages.

P31

scholarly article

P356

10.1128/AAC.01208-18

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30104268

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

infectious disease

P932

6153809

http://www.w3.org/2001/XMLSchema#string